Investing.com - Bernstein SocGen Group raised its price target on Beam Therapeutics Inc (NASDAQ:BEAM) to $37.00 from $32.00 on Monday, while maintaining an Outperform rating on the stock. The new ...
This project provides a Python-based toolkit for tracking and analyzing the actuation of cantilever beams from video data. It leverages OpenCV and scientific Python libraries to extract quantitative ...
BEAM-101 is an investigational genetically modified cell therapy for the treatment of severe sickle cell disease (SCD). The one-time therapy consists of autologous CD34+ hematopoietic stem and ...
CAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the ...
A program that follows the finite element method with 1-D elements. This is program was created as a semester project for the class Matrix Structural Analysis - 1D finite elements of the NTUA's School ...
Abstract: This study aims to provide an enhanced approach to analyze circuits using matrix analysis and Kirchhoff's Current Law (KCL). Matrices were employed for the integration of power parameters, ...
SAN DIEGO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Beam Global, (Nasdaq: BEEM, BEEMW), a leading provider of innovative and sustainable infrastructure solutions for the electrification of transportation and ...
Each February during American Heart Month, there’s an increased focus on heart disease – the leading cause of death in the U.S. But the focus is often limited to the most common form, coronary heart ...
Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Note: Hover over the donut graph to view ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results